Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...

Heron Therapeutics Inc (HRTX) stock saw a modest uptick, ending the day at $2.02 which represents a slight increase of $0.07 or 3.59% from the prior close of $1.95. The stock opened at $1.99 and ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $36.41 which represents a slight increase of $2.07 or 6.03% from the prior close of $34.34. The stock opened at $35.06 and ...

Zevra Therapeutics Inc. (ZVRA) made headlines yesterday with a landmark FDA approval for its innovative drug, MIPLYFFA, in the ...

We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers. In this article, we are ...

KarXT, a novel schizophrenia drug, is on the verge of FDA approval, promising to revolutionize treatment. However, access ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

Rachel Dalthorp, MD, discusses how zuranolone (Zurzuvae) can improve postpartum depression when compared with previous ...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 0.2% on Friday. The Dow traded ...

That's why we made it our mission to identify the absolute best cortisol supplements on the market in 2024. We've analyzed ...

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 0.5% on Friday. The Dow ...